CNTX - Financial Reports List - Context Therapeutics Inc. - IntrinsicAlpha

Context Therapeutics Inc. CNTX

Healthcare - Biotechnology - NASDAQ - US

$ 0.691

1.8 %

$ 62 M

Market Cap

-2.47

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	-24.80%	-44.61%
Quarterly Report	Q4	8-K	2024-12-31	0.00%	50.62%	37.83%
Annual Report	FY	10-K	2024-12-31	0.00%	-11.52%	-19.35%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-197.21%	-202.59%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	55.01%	41.64%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	38.36%	42.65%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-90.34%	-78.58%
Annual Report	FY	10-K	2023-12-31	0.00%	-67.69%	-63.01%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-60.49%	-52.68%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-26.38%	-32.05%

1